Press release
Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the generic version of Novartis Pharmaceuticals Corp's Gleevec tablets 100mg and 400 mg.A full report of Imatinib Drug Market is available at: https://www.omrglobal.com/industry-reports/imatinib-drug-market
In October 2018, Dr. Reddy’s Laboratories, Ltd. announced the launch of its Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version Gleevec tablets in the United States market for the treatment of different types of cancer. Imatinib Mesylate is a US FDA approved drug for commercial sale in the US which is expected to boost the imatinib market in the country. Imatinib Mesylate tablets are available in two different strengths i.e. 100 mg and 400 mg.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/imatinib-drug-market
In September 2017, Mylan N.V. announced the US launch of Imatinib Mesylate Tablets in 100 mg and 400 mg generic version. Mylan received final approval from the U.S Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Imatinib Mesylate tablets can be used for multiple indications including Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES) and aggressive systemic mastocytosis (ASM).
Imatinib Drug Market Segmentation
By Drug Form
• Tablet
• Capsule
By Application
• Blood Cancer (Leukemia and Other Blood Cancers)
• Gastrointestinal Stromal Tumors (GIST)
• Skin Tumors (Dermatofibrosarcoma Protuberans)
• Other Tumors (Systemic Mastocytosis)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/imatinib-drug-market
Imatinib Drug Market – Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Apotex Inc.
• Cipla, Inc.
• Dr. Reddy’s Laboratory, Ltd.
• Glenmark Pharmaceutical, Ltd.
• Lupin, Ltd.
• Mylan N.V.
• Novartis AG
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industry, Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2020-2026 here
News-ID: 2216659 • Views: …
More Releases from Orion Market Research
Enterprise Resource Planning (ERP) Software Market Size, Trends, Latest Insights …
The global Enterprise Resource Planning (ERP) Software market is expected to grow at a considerable CAGR of 8.4% during the forecast period. Businesses are increasingly engaging in mergers and acquisitions (M&A) to expand their market share. ERP software can help businesses to integrate their acquired businesses and streamline their operations. Mergers and acquisitions (M&A) are strategic moves undertaken by businesses to expand their reach, enhance their capabilities, and gain a competitive edge.…
Flight Simulator Market Size, Trends, Latest Insights, Analysis and Forecast 202 …
The global flight simulator market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The market developments such as new product launches and collaboration among key players is a key factor driving the growth of the global market. For instance,
in May 2023, Lilium N.V., developer of the first all-electric vertical take-off and landing (eVTOL) jet, partnered with FlightSafety International (FSI) for the development of flight training devices.…
Automotive Relay Market Growth Probability, Leading Vendors and Future Scenario …
Automotive relay market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2023-2030). The growing automotive industry is a key factor driving the demand for the global automotive relay market. An automotive relay is a type of electrical switch that works as a control device within a vehicle. It manages the flow of electrical energy within various systems and helps in controlling and automating electrical…
Hub Motor Market is Dazzling Worldwide and Forecast to 2031
The global hub motor market is anticipated to grow at a moderate CAGR of 4.9% during the forecast period (2024-2031). Globally, with the growth in EV sales and rapid technological advancements such as Advanced Driver Assistance Systems (ADAS), companies are focusing on R&D and portfolio expansion which is driving overall demand for the hub motor market. For instance,In March 2023, Hyundai Mobis announced it successfully developed an in-wheel system, allowing direct motor…
More Releases for Imatinib
Imatinib Drug Market Report- Business Review, Technology, Top Companies and Tren …
The Imatinib Drug Market research report studies the competitive development of the Imatinib Drug Market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Imatinib Drug Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
Global Imatinib Drug Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global imatinib drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities…
Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used…
Imatinib Drugs Market to Witness Huge Growth by Key Players: Apotex, Novartis, S …
A new business intelligence report released by HTF MI with title “Global Imatinib Drugs Market Insights, Forecast to 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends.
Request Sample Report @: https://www.htfmarketreport.com/sample-report/1618310-global-imatinib-drugs-market-5
If you…
China Imatinib Mesylate Market Research Report 2018
The China Imatinib Mesylate Market Research Report 2018 is a professional and in-depth study on the current state of the Imatinib Mesylate industry.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Imatinib Mesylate Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures.…
